NYSE: NKENike Inc Stock
$64.17-1.86 (-2.82%)
Updated Nov 14, 2025
NKE Price
$64.17
Fair Value Price
N/A
Market Cap
$94.86B
52 Week Low
$52.28
52 Week High
$82.44
P/E
32.74x
P/B
7.04x
P/S
2.46x
PEG
1.86x
Dividend Yield
2.49%
Revenue
$46.44B
Earnings
$2.90B
Gross Margin
41.9%
Operating Margin
7.36%
Profit Margin
6.2%
Debt to Equity
1.77
Operating Cash Flow
$4B
Beta
1.1
Next Earnings
Dec 18, 2025
Ex-Dividend
N/A
Next Dividend
N/A
NKE Overview
NIKE, Inc. sells athletic footwear, apparel, equipment, and accessories in the U.S. and internationally. It also offers products for kids. NIKE was founded in 1964 and is headquartered in Beaverton, OR.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NKE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shoe
Industry Rating
C
NKE
Ranked#9 of 14
Ranked#9 of 14
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $30.14 | A | |
| $15.44 | B | |
| $34.76 | C |
Be the first to know about important NKE news, forecast changes, insider trades & much more!
NKE News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NKE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NKE ($64.17) is trading above its intrinsic value of $24.17, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NKE is good value based on its earnings relative to its share price (32.74x), compared to the US market average (44.96x)
P/E vs Market Valuation
NKE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NKE due diligence checks available for Premium users.
Valuation
NKE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
32.74x
Industry
31.77x
Market
44.96x
NKE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NKE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NKE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
7.04x
Industry
5.61x
NKE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NKE price to earnings growth (PEG)
For valuing profitable companies with growth potential
NKE is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
NKE's financial health
Profit margin
Revenue
$11.7B
Net Income
$727.0M
Profit Margin
6.2%
NKE's Earnings (EBIT) of $3.42B... subscribe to Premium to read more.
Interest Coverage Financials
NKE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$37.3B
Liabilities
$23.9B
Debt to equity
1.77
NKE's short-term assets ($23.90B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NKE's short-term assets ($23.90B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NKE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NKE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$222.0M
Investing
-$59.0M
Financing
-$598.0M
NKE's operating cash flow ($3.53B)... subscribe to Premium to read more.
Debt Coverage Financials
NKE vs Shoe Stocks
Nike Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.